IQVIAIQVEarnings & Financial Report
NYSE · Health Care · Life Sciences Tools & Services
IQVIA Holdings, Inc., headquartered in Durham, North Carolina, is an American company focused on health information technology and clinical research.
IQV Q1 FY2026 Key Financial Metrics
Revenue
$4.2B
Gross Profit
N/A
Operating Profit
$514.0M
Net Profit
$275.0M
Gross Margin
N/A
Operating Margin
12.4%
Net Margin
6.6%
YoY Growth
8.4%
EPS
$1.61
IQVIA Q1 FY2026 Financial Summary
IQVIA reported revenue of $4.2B (up 8.4% YoY) for Q1 FY2026, with a net profit of $275.0M (up 10.0% YoY) (6.6% margin).
Key Financial Metrics
| Total Revenue | $4.2B |
|---|---|
| Net Profit | $275.0M |
| Gross Margin | N/A |
| Operating Margin | 12.4% |
| Report Period | Q1 FY2026 |
IQVIA Annual Revenue by Year
IQVIA annual revenue history includes year-by-year totals (for example, 2025 revenue was $16.3B).
IQVIA Quarterly Revenue & Net Profit History
IQVIA results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q1 FY2026 | $4.2B | +8.4% | $275.0M | 6.6% |
| Q4 FY2025 | $4.4B | +10.3% | $514.0M | 11.8% |
| Q3 FY2025 | $4.1B | +5.2% | $331.0M | 8.1% |
| Q2 FY2025 | $4.0B | +5.3% | $266.0M | 6.6% |
| Q1 FY2025 | $3.8B | +2.5% | $249.0M | 6.5% |
| Q4 FY2024 | $4.0B | +2.3% | $437.0M | 11.0% |
| Q3 FY2024 | $3.9B | +4.3% | $285.0M | 7.3% |
| Q2 FY2024 | $3.8B | +2.3% | $363.0M | 9.5% |
Income Statement
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.81B | $3.90B | $3.96B | $3.83B | $4.02B | $4.10B | $4.36B | $4.15B |
| YoY Growth | 2.3% | 4.3% | 2.3% | 2.5% | 5.3% | 5.2% | 10.3% | 8.4% |
Balance Sheet
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $26.40B | $27.18B | $26.90B | $27.32B | $28.63B | $28.73B | $29.94B | $29.68B |
| Liabilities | $19.68B | $20.21B | $20.83B | $21.34B | $22.85B | $22.44B | $23.31B | $23.33B |
| Equity | $6.71B | $6.97B | $6.07B | $5.98B | $5.78B | $6.16B | $6.50B | $6.35B |
Cash Flow
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $588.0M | $721.0M | $885.0M | $568.0M | $443.0M | $908.0M | $735.0M | $618.0M |